Sugi Predict

Sugi Predict / Compounds / SCHEMBL9956029

SCHEMBL9956029

SCHEMBL9956029

Cc1ccc(-c2cn3nc(-c4ccc(NC(=O)CCCCCCC(=O)O)cc4)ccc3n2)cc1NC(=O)C(C)(C)C

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ MAPT P10636 7/20 0.42
▸ TP53 P04637 6/20 0.42
▸ LMNA P02545 5/20 0.42
▸ RXFP1 Q9HBX9 3/20 0.42
▸ RAB9A P51151 4/20 0.39
▸ ALDH1A1 P00352 4/20 0.39
▸ SMN1; SMN2 Q16637 3/20 0.39
▸ HPGD P15428 2/20 0.39
▸ GFER P55789 1/20 0.39
▸ CSNK1D P48730 2/20 0.38
▸ CSNK1E P49674 2/20 0.38
▸ GAA P10253 2/20 0.38
▸ KDM4E B2RXH2 2/20 0.38
▸ GLA P06280 1/20 0.38
▸ RIPK1 Q13546 1/20 0.37
▸ MEN1 O00255 2/20 0.37
▸ POLB P06746 2/20 0.37
▸ KMT2A Q03164 2/20 0.37
▸ NPC1 O15118 1/20 0.37
▸ TSHR P16473 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9955659 0.94 HDAC1 (0.43) MAPTTP53LMNARXFP1RAB9A
SCHEMBL9954927 0.93 TP53 (0.43) MAPTTP53LMNARXFP1RAB9A
SCHEMBL9956895 0.84 NPC1 (0.38) MAPTTP53LMNARXFP1RAB9A
SCHEMBL9956711 0.83 HDAC1 (0.38) MAPTTP53LMNARXFP1CSNK1D
SCHEMBL9957565 0.83 CSNK1D (0.44) MAPTTP53LMNARXFP1CSNK1D
SCHEMBL9955744 0.82 HDAC1 (0.39) MAPTTP53LMNARXFP1CSNK1D
SCHEMBL9956513 0.82 RXFP1 (0.39) MAPTTP53LMNARXFP1SMN1; SMN2
SCHEMBL9957221 0.82 CSNK1D (0.44) MAPTTP53LMNARXFP1ALDH1A1
SCHEMBL9957147 0.82 CSNK1D (0.44) MAPTTP53LMNARXFP1RAB9A
SCHEMBL9955933 0.82 HDAC3 (0.39) MAPTTP53RXFP1CSNK1DCSNK1E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2635578-A1 2-ARYLIMIDAZO[1,2-B]PYRIDAZINE, 2-PHENYLIMIDAZO[1,2-A]PYRIDINE, AND 2-PHENYLIMIDAZO[1,2-A]PYRAZINE DERIVATIVES Hengrui (USA) Ltd. (US) 2013-09-11 — — EP claimed
US-20120178751-A1 2-ARYLIMIDAZO[1,2-B]PYRIDAZINE, 2-PHENYLIMIDAZO[1,2-A]PYRIDINE, AND 2-PHENYLIMIDAZO[1,2-A]PYRAZINE DERIVATIVES HENGRUI (USA), LTD. 2012-07-12 — — US claimed
WO-2012088411-A1 2-ARYLIMIDAZO[1,2-B]PYRIDAZINE, 2-PHENYLIMIDAZO[1,2-A]PYRIDINE, AND 2-PHENYLIMIDAZO[1,2-A]PYRAZINE DERIVATIVES PAMLICO PHARMACEUTICAL INC. (US) 2012-06-28 — — WO claimed
EP-2635578-B1 2-ARYLIMIDAZO[1,2-B]PYRIDAZINE, 2-PHENYLIMIDAZO[1,2-A]PYRIDINE, AND 2-PHENYLIMIDAZO[1,2-A]PYRAZINE DERIVATIVES HENGRUI USA LTD (US) 2015-12-16 — — EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120178751-A1 2-ARYLIMIDAZO[1,2-B]PYRIDAZINE, 2-PHENYLIMIDAZO[1,2-A]PYRIDINE, AND 2-PHENYLIMIDAZO[1,2-A]PYRAZINE DERIVATIVES PRXL2A, CDK2, CCNA2 MAPT 4038/4885TP53 10/4885LMNA 966/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.